申请人:Burroughs Wellcome Co.
公开号:US04036961A1
公开(公告)日:1977-07-19
Pharmaceutical compositions containing the pteridines of formula (I), ##STR1## wherein R is a lower alkyl group, substituted with one or more halogen atoms, and R.sup.1 and R.sup.2 are the same or different and each is a lower alkyl group or R.sup.1 and R.sup.2, together with the carbon atom in the pteridine ring structure, form a spirocycloalkyl ring system having 4 to 6 carbon atoms outside the pteridine ring structure. The above compositions have bacteriostatic activity.
含有式(I)中的蝶啶类化合物的制药组合物,其中式中R是低碳基,被一个或多个卤素原子取代,而R1和R2相同或不同,且每个都是低碳基,或者R1和R2连同蝶啶环结构中的碳原子形成一个在蝶啶环结构外具有4到6个碳原子的螺环烷基环系统。上述组合物具有细菌抑制活性。